Corriente Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Corriente Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,794	Closed	-$7.87M	–	9
2021 Q3	$7.87M	Buy	+40,794	New	+$8.66M	15.2%	3
2021 Q2	–	Sell	-62,627	Closed	-$21.2M	–	19
2021 Q1	$21.2M	Buy	62,627 +8,627	+16%	+$3.51M	7.82%	6
2020 Q4	$19.3M	Buy	54,000 +11,647	+27%	+$4.48M	4.6%	8
2020 Q3	$19.6M	Buy	+42,353	New	+$12M	9.92%	5

Other funds holding TFFP

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PCM

Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

Corriente Advisors's TFFP Position: Q4 2021 in Review

Corriente Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2021, closing a stake of 40,794 shares — an estimated $7.87M sold.

Corriente Advisors first reported a position in TFFP in Q3 2020 and held it in 4 quarters. The position peaked at $21.2M in Q1 2021. 51 funds tracked by Wall St. Rank hold TFFP as of Q4 2021.

Corriente Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Corriente Advisors sold 40,794 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $7.87M.
Corriente Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Corriente Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $21.2M in Q1 2021.
51 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Corriente Advisors's 13F filing for Q4 2021, filed 15 Feb 2022.